Cargando…

Reversible Adaptive Plasticity: A Mechanism for Neuroblastoma Cell Heterogeneity and Chemo-Resistance

We describe a novel form of tumor cell plasticity characterized by reversible adaptive plasticity in murine and human neuroblastoma. Two cellular phenotypes were defined by their ability to exhibit adhered, anchorage dependent (AD) or sphere forming, anchorage independent (AI) growth. The tumor cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Lina, Abou-Antoun, Thamara, Vukmanovic, Stanislav, Sandler, Anthony D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412992/ https://www.ncbi.nlm.nih.gov/pubmed/22891161 http://dx.doi.org/10.3389/fonc.2012.00082

Ejemplares similares

Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance
por: Abou-Antoun, Tamara J., et al.
Publicado: (2018)

A Mechanism Linking Id2-TGFβ Crosstalk to Reversible Adaptive Plasticity in Neuroblastoma
por: Chakrabarti, Lina, et al.
Publicado: (2013)

A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells
por: Hanna, Reine, et al.
Publicado: (2021)

Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
por: Lundberg, Kristina Ihrmark, et al.
Publicado: (2022)

Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration
por: Zaatiti, Hayat, et al.
Publicado: (2018)

Editorial: Chemo-Resistance in Gastrointestinal Cancers
por: Li, Xia, et al.
Publicado: (2022)

Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model
por: Chakrabarti, Lina, et al.
Publicado: (2015)

Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
por: Ahmed, Farzana, et al.
Publicado: (2018)

The modulation of ion channels in cancer chemo-resistance
por: Zhao, Jiayu, et al.
Publicado: (2022)

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma
por: Li, Chao, et al.
Publicado: (2022)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma
por: Liu, Xiaomei, et al.
Publicado: (2022)

Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
por: Zhou, Xia, et al.
Publicado: (2023)

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015)

Chemo Heart
por: DeFilippis, Ersilia M.
Publicado: (2017)

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer
por: Zhao, Xiao-Yin, et al.
Publicado: (2022)

Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
por: Bahmad, Hisham F., et al.
Publicado: (2019)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

Heterogeneity of neuroblastoma
por: Ngan, Elly Sau-Wai
Publicado: (2015)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs
por: Bousoik, Emira, et al.
Publicado: (2019)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Metabolic Plasticity in Chemotherapy Resistance
por: Desbats, Maria Andrea, et al.
Publicado: (2020)

Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
por: Malik, Prabhat Singh, et al.
Publicado: (2014)

Impact of Chemotherapy on Extracellular Vesicles: Understanding the Chemo-EVs
por: Ab Razak, Nur' Syahada, et al.
Publicado: (2019)

A Model-System to Address the Impact of Phenotypic Heterogeneity and Plasticity on the Development of Cancer Therapies
por: Jong, Eric D., et al.
Publicado: (2019)

A Comparison Between Chemo-Radiotherapy Combined With Immunotherapy and Chemo-Radiotherapy Alone for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
por: Lara-Velazquez, Montserrat, et al.
Publicado: (2021)

MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021)

Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)

Transcriptional Activation of Gstp1 by MEK/ERK Signaling Confers Chemo-Resistance to Cisplatin in Lung Cancer Stem Cells
por: Li, Jingyuan, et al.
Publicado: (2019)

The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia
por: Zhu, Hong-Hu
Publicado: (2020)

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity
por: Jolly, Mohit Kumar, et al.
Publicado: (2018)

Wilms’ Tumor 1-Associated Protein Contributes to Chemo-Resistance to Cisplatin Through the Wnt/β-Catenin Pathway in Endometrial Cancer
por: Xie, Wenli, et al.
Publicado: (2021)

Case Report: An “Immune-Cold” EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy
por: Zhao, Qian, et al.
Publicado: (2022)

GAPDH in neuroblastoma: Functions in metabolism and survival
por: Cornett, Kevin, et al.
Publicado: (2022)

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism
por: Yin, Delong, et al.
Publicado: (2021)

NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor Growth
por: Vallejo, Frederic A., et al.
Publicado: (2022)

Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
por: Huang, Fan, et al.
Publicado: (2021)

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
por: Thirant, Cécile, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i1i3hqk3smbok7o6vj26g36r2g